about
Long non-coding RNAs in nervous system function and diseaseThe Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple SclerosisNovel Insights and Therapeutics in Multiple SclerosisThe immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS)The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cellsCD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosisIs Multiple Sclerosis an Autoimmune Disease?Analysis of the paired TCR α- and β-chains of single human T cellsThe retrovirus/superantigen hypothesis of multiple sclerosis.Therapeutic interference with leukocyte recirculation in multiple sclerosis.Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice.Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.Contribution of genetic, epigenetic and transcriptomic differences to twin discordance in multiple sclerosis.Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a reviewThe neuropathological basis of clinical progression in multiple sclerosis.The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice.Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides.Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseasesαβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related featuresIdentification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors.CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritisThe proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditisWhat do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?Pathoetiology of multiple sclerosis: are we barking up the wrong tree?Can vitamin d suppress endothelial cells apoptosis in multiple sclerosis patients?The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.Impaired toll-like receptor 8 signaling in multiple sclerosis.Modeling the heterogeneity of multiple sclerosis in animalsWnt signaling inhibits CTL memory programming.Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies.CD8(+) T cells in multiple sclerosis.Using EAE to better understand principles of immune function and autoimmune pathologyTeriflunomide and its mechanism of action in multiple sclerosis.T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies.Risk conferring genes in multiple sclerosis.The molecular basis of neurodegeneration in multiple sclerosis.Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.
P2860
Q24595656-3EC4023C-C500-44DA-8C7F-12379F927507Q26777944-31B9FF70-C9DB-47AB-ACCA-83640195C46CQ26784619-C0E51D35-D71E-4417-935B-63C79ED18C05Q26823691-6C84B325-0366-4D3C-A38F-6C4C2920B243Q26858844-1E80DF9F-0AC8-425D-AEDD-F416D1B69A95Q27320766-F140AAED-B464-4CF2-961A-0F5EA4557FF3Q27496011-6DDD6E33-FDCD-4A45-89A3-4C04D5F0F9FCQ28729281-7304A5BC-31EC-470C-BD34-CCC7EFCBEE15Q30317136-9740D8DE-5708-4298-A350-B9947A9FDD21Q30884219-8B4335BE-54E3-4110-8AB6-6B7B94677AB3Q33597044-3E53735A-56FA-44B1-A3A0-1EED7B87CED4Q33760897-EFD570B0-5CC2-493B-96D1-95126238732FQ34136311-E723B927-F6C5-4159-BC46-5566707839EEQ34158137-4B4550F2-051C-48F5-8A74-D9A844DC9E8EQ34188436-B3958ADF-C988-41E9-97C1-6586DCF4048BQ34203715-C52DE3CB-456F-41E5-91F6-1202B2AC9887Q34224580-5D01B6FE-2B08-4F87-8A91-5475F2B03180Q35175394-68BA600E-BA45-450E-A7A2-621D5BCBEBFCQ35632530-C7AB789E-DDC5-4666-95D5-4C4946E451BFQ35914856-7A1C29C5-D514-4854-9190-E204291AD628Q35982368-D88314A8-FD95-40C8-AEA5-6D4B1B41E333Q36190935-953ECF15-32C3-47F0-A1AC-1BF6FB34A99DQ36396476-D4C00335-F62A-4175-8A16-CDA412DD7543Q36904407-10829BDD-D678-4992-8899-BB0B0EB53405Q36917731-2CB406D7-DB1A-48BE-8487-720CE7476975Q36917904-B857C7A9-D50F-4DCF-A250-7C2600475CBEQ36952930-339A5FE8-CAB8-4778-9B9B-7AC1FC1E94FFQ37119854-71AFF4B0-48E1-40F7-B378-282120BD1756Q37198555-2A793427-0D12-4E56-B4EC-5DD0BB444A26Q37313736-1A7D0899-C2C8-408F-9FBA-08EDDA0E1A4EQ37313740-28BB7972-CFA7-4F06-853D-0EA565FC44A5Q37342952-8D88DBB5-B892-4FCE-8D1C-C2DEAFE75DF8Q37591260-AE906C12-9E76-45DC-A61D-07B47925E0B8Q37657501-E267287F-8556-4A2E-B9FE-15CB75F1BE4EQ37730005-33781E47-CCF9-4C00-97FB-0E9D3036C8C3Q37777431-45C8DF0E-7379-484F-A63E-128F6447E839Q37820728-28CCE246-C4EC-4A1D-8E30-9E485DA923A0Q37857943-5F90CABF-BB5A-4059-935C-87712EDA2331Q37920009-ED1EF6B6-C677-4027-A573-E005B3E40818Q37990779-F7B37843-EE95-44CE-B9B5-D7120F2C52A1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenic CD8
@nl
Pathogenic CD8(+) T cells in multiple sclerosis.
@en
type
label
Pathogenic CD8
@nl
Pathogenic CD8(+) T cells in multiple sclerosis.
@en
prefLabel
Pathogenic CD8
@nl
Pathogenic CD8(+) T cells in multiple sclerosis.
@en
P2860
P356
P1433
P1476
Pathogenic CD8(+) T cells in multiple sclerosis.
@en
P2093
Lars Fugger
Manuel A Friese
P2860
P304
P356
10.1002/ANA.21744
P577
2009-08-01T00:00:00Z